CD24 and breast carcinoma: More interestingly, PDL192 response was found to be impacted by one EMT-related gene (vi) (VIM) and two cancer stem cell-related genes (vii and viii) (CD24 and CD133), both processes of high importance in breast cancer progression [40], [41], [42].